Halldén G - Search Results

1

Designer Oncolytic Adenovirus: Coming of Age.

Baker AT, Aguirre-Hernández C, Halldén G, Parker AL. Baker AT, et al. Among authors: hallden g. Cancers (Basel). 2018 Jun 14;10(6):201. doi: 10.3390/cancers10060201. Cancers (Basel). 2018. PMID: 29904022 Free PMC article. Review.

2

Oncolytic adenovirus-mediated therapy for prostate cancer.

Sweeney K, Halldén G. Sweeney K, et al. Among authors: hallden g. Oncolytic Virother. 2016 Jul 14;5:45-57. doi: 10.2147/OV.S63047. eCollection 2016. Oncolytic Virother. 2016. PMID: 27579296 Free PMC article. Review.

3

Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad∆∆ through Bcl-2-dependent attenuation of autophagy.

Aguirre-Hernández C, Maya-Pineda H, Millán JS, Man YKS, Lu YJ, Halldén G. Aguirre-Hernández C, et al. Among authors: hallden g. Oncogenesis. 2018 Jan 24;7(1):6. doi: 10.1038/s41389-017-0020-8. Oncogenesis. 2018. PMID: 29362360 Free PMC article.

4

The Novel Oncolytic Adenoviral Mutant Ad5-3Δ-A20T Retargeted to αvβ6 Integrins Efficiently Eliminates Pancreatic Cancer Cells.

Man YKS, Davies JA, Coughlan L, Pantelidou C, Blázquez-Moreno A, Marshall JF, Parker AL, Halldén G. Man YKS, et al. Among authors: hallden g. Mol Cancer Ther. 2018 Feb;17(2):575-587. doi: 10.1158/1535-7163.MCT-17-0671. Mol Cancer Ther. 2018. PMID: 29367266

5

Advances in oncolytic adenovirus therapy for pancreatic cancer.

Nattress CB, Halldén G. Nattress CB, et al. Among authors: hallden g. Cancer Lett. 2018 Oct 10;434:56-69. doi: 10.1016/j.canlet.2018.07.006. Epub 2018 Jul 5. Cancer Lett. 2018. PMID: 29981812 Review.

6

Systemic delivery and SPECT/CT in vivo imaging of ¹²⁵I-labelled oncolytic adenoviral mutants in models of pancreatic cancer.

Stella Man YK, Foster J, Carapuça E, Davies JA, Parker AL, Sosabowski J, Halldén G. Stella Man YK, et al. Among authors: hallden g. Sci Rep. 2019 Sep 6;9(1):12840. doi: 10.1038/s41598-019-49150-9. Sci Rep. 2019. PMID: 31492884 Free PMC article.

7

Complexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Models.

Man YKS, Aguirre-Hernandez C, Fernandez A, Martin-Duque P, González-Pastor R, Halldén G. Man YKS, et al. Among authors: hallden g. Int J Mol Sci. 2022 Aug 10;23(16):8884. doi: 10.3390/ijms23168884. Int J Mol Sci. 2022. PMID: 36012152 Free PMC article.

8

Virus-associated RNA I-deleted adenovirus, a potential oncolytic agent targeting EBV-associated tumors.

Wang Y, Xue SA, Hallden G, Francis J, Yuan M, Griffin BE, Lemoine NR. Wang Y, et al. Among authors: hallden g. Cancer Res. 2005 Feb 15;65(4):1523-31. doi: 10.1158/0008-5472.CAN-04-3113. Cancer Res. 2005. PMID: 15735041 Free article.

9

Optimisation of replication-selective oncolytic adenoviral mutants in combination with chemotherapeutics.

Halldén G. Halldén G. J BUON. 2009 Sep;14 Suppl 1:S61-7. J BUON. 2009. PMID: 19785071 Review.

10

Adenovirus-based therapy for prostate cancer.

Ekblad M, Halldén G. Ekblad M, et al. Among authors: hallden g. Curr Opin Mol Ther. 2010 Aug;12(4):421-31. Curr Opin Mol Ther. 2010. PMID: 20677093 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

122 results

Search Page